I rate Bio-Rad (BIO) with a buy rating. I start by mentioning that the low growth perspective is the negative aspect. For 2025, the company expects a 0.25% growth rate for its revenues, which might ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback